Comparative serum protein binding of anthracycline derivatives

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 6, 1996, Pages 571-573

  Chassany, Olivier ^a   Urien, Saïk ^a   Claudepierre, Pascal ^a   Bastian, Gérard ^b   Tillement, Jean Paul ^a  

^a FACULTÉ DE MÉDECINE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Alpha1 acid glycoprotein; Anthracycline derivatives; Human serum albumin; Hydrophobicity; Serum protein binding

Indexed keywords

4' IODOESORUBICIN; ACLARUBICIN; ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; HUMAN SERUM ALBUMIN; MITOXANTRONE; OROSOMUCOID; PIRARUBICIN; ZORUBICIN;

ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANTIBIOTICS, ANTINEOPLASTIC; HUMANS; OROSOMUCOID; PROTEIN BINDING; SERUM ALBUMIN;

EID: 0029840968     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050529     Document Type: Article

References (9)

1. Albengres E, Urien S, Pognat JF, Tillement JP (1984) Multiple binding of bepridil in human blood. Pharmacology 28: 139-149
2. Chassany O, Urien S, Claudepierre P, Bastian G, Tillement JP (1994) Binding of anthracycline derivatives to human serum lipoproteins. Anticancer Res 14: 1-3
3. Eksborg S, Ehrsson H, Ekqvist B (1982) Protein binding of anthraquinone glycosides with special reference to Adriamycin. Cancer Chemother Pharmacol 10: 7-10
4. Fitos I, Visy J, Simonyi M (1991) Binding of vinca alkaloid analogues to human serum albumin and to alphal-acid glycoprotein. Biochem Pharmacol 41: 377-383
5. Mross K, Mayer U, Hamm K, Burk K, Hossfeld DK (1990) Pharmacokinetics and metabolism of iodo-doxorubicin in humans. Eur J Clin Pharmacol 39: 507-513
6. Robert J (1980) Extraction of anthracyclines from biological fluids for HPLC determination. J Liquid Chromatogr 3: 1561-1572
7. Routledge PA (1986) The plasma protein binding of basic drugs. Br J Clin Pharmacol 22: 499-506
8. Stewart CF, Fleming RA, Arbuck SG, Evans WE (1990) Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients. Cancer Res 50: 6854-6856
9. Urien S, Riant P, Renouard A, Coulomb A, Rocher I, Tillement JP (1988) Binding of indapamide to serum proteins and erythrocytes. Biochem Pharmacol 147: 2964-2966